MIDLAND, MI and SAINT JOHNS, MI / ACCESSWIRE / November 14, 2024 / Michigan Psychological Care is excited to announce the ...

CaaMTech's New Clinical Trial Design Solves the Emergent Functional Unblinding Problems Plaguing Psychedelic Medicine DevelopersISSAQUAH, WA / ACCESSWIRE / November 14, 2024 / CaaMTech, Inc. is ...

BROOMFIELD, CO / ACCESSWIRE / November 14, 2024 / Aclarion, Inc., ("Aclarion" or the "Company") (Nasdaq:ACON)(Nasdaq:ACONW), a healthcare technology company that is leveraging biomarkers and ...

Health's ful. CashPay addresses a critical gap, helping HR leaders offer affordable healthcare solution to uninsured, part-time employeesDUBUQUE, IA / ACCESSWIRE / November 14, 2024 / As Open ...

NORTHVALE, NJ / ACCESSWIRE / November 14, 2024 / ADM Tronics Unlimited, Inc. (OTCQB:ADMT), a technology-based developer and manufacturer of innovative technologies and products, announces results for ...

The integration of AI in life science recruitment is already reshaping hiring processes by offering increased efficiency, ...

Breaking down the silos between departments opens up an exciting new level of efficiency, cost savings, communication, and faster, more informed decision-making.SAN FRANCISCO, CA / ACCESSWIRE / ...

Talent consulting start-up, pobl., is thrilled to announce the addition of Lindsey Heer to its team. Lindsey, an experienced leader in medical communications, with foundations in the pharmaceutical ...

Aravax, a clinical-stage biotechnology company developing next-generation immunotherapies designed to be safe, convenient, and precisely targeted, today announces it has established a UK subsidiary, ...

WELLINGTON, FL / ACCESSWIRE / November 14, 2024 / Cellev8 Nutrition Inc (OTC PINK:CELV), formerly known as Preferred Commerce, today issued a statement to clarify its business focus and retract ...

Chiesi Group, an international biopharmaceutical company focused on research, has been named one of the 25 World’s Best Workplaces™ in 2024 by Great Place To Work® (GPTW) and Fortune magazine, ranking ...

Sea's novel synthetic molecules act at the neurotransmitter glutamate pathway on two clinically validated targets in the central nervous system, "the CNS"Two potent, selective, pre-clinical stage ...